French Registry of Adult Patients With Immune Thrombocytopenia and Autoimmune Hemolytic Anemia

Last updated: August 26, 2024
Sponsor: University Hospital, Toulouse
Overall Status: Active - Recruiting

Phase

N/A

Condition

Anemia

Immune (Idiopathic) Thrombocytopenic Purpura (Itp)

Lupus

Treatment

no specific intervention

Clinical Study ID

NCT02877706
RC31/12/0386
  • Ages > 18
  • All Genders

Study Summary

CARMEN is a national, real-world clinical registry of all adult patients with incident diagnosis of Immune thrombocytopenia (ITP) or Autoimmune Hemolytic anemia (AIHA) patients in France. It is aimed at describing ITP and AIHA clinical features, assessing the real-world risk-benefit ratio of treatments and adherence to guidelines for ITP and AIHA management.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • adult patients (18+ year-old)

  • newly diagnosed for ITP/AIHA or initiation of FOSFAMATINIB

Exclusion

Exclusion criteria:

  • opposition to data collection

Study Design

Total Participants: 1500
Treatment Group(s): 1
Primary Treatment: no specific intervention
Phase:
Study Start date:
June 01, 2013
Estimated Completion Date:
June 30, 2029

Connect with a study center

  • Service de Médecine Interne

    Toulouse, 31000
    France

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.